BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
iShares MSCI ACWI Low Carbon Target ETF
CRBN
$1.07B
| $174K | ﹤0.01% |
898
-81
| -8% | -$15.7K |
|
2952
Ceragon Networks
CRNT
$179M
| $173K | ﹤0.01% |
+37,019
| New | +$173K |
|
2953
Tronox
TROX
$767M
| $172K | ﹤0.01% |
17,075
-69,454
| -80% | -$699K |
|
2954
Nature's Sunshine
NATR
$299M
| $172K | ﹤0.01% |
11,719
+9,097
| +347% | +$133K |
|
2955
Foster
FSTR
$291M
| $171K | ﹤0.01% |
6,368
+4,225
| +197% | +$114K |
|
2956
Banco Macro
BMA
$2.8B
| $171K | ﹤0.01% |
1,767
-49,560
| -97% | -$4.8M |
|
2957
LGI Homes
LGIH
$1.39B
| $170K | ﹤0.01% |
1,896
-22,951
| -92% | -$2.05M |
|
|
TRVG
2958
trivago
TRVG
$238M
| $169K | ﹤0.01% |
77,458
-119
| -0.2% | -$259 |
|
2959
Kyverna Therapeutics
KYTX
$170M
| $168K | ﹤0.01% |
44,983
+17,786
| +65% | +$66.5K |
|
2960
German American Bancorp
GABC
$1.53B
| $168K | ﹤0.01% |
4,180
-2,040
| -33% | -$82K |
|
|
LAND
2961
Gladstone Land Corp
LAND
$321M
| $168K | ﹤0.01% |
15,484
+4,075
| +36% | +$44.2K |
|
2962
Sapiens International
SPNS
$2.4B
| $168K | ﹤0.01% |
6,240
-10,412
| -63% | -$280K |
|
2963
Artesian Resources
ARTNA
$340M
| $167K | ﹤0.01% |
5,290
-1,802
| -25% | -$57K |
|
|
JBGS
2964
JBG SMITH
JBGS
$1.45B
| $167K | ﹤0.01% |
10,876
-7,669
| -41% | -$118K |
|
2965
Eventbrite
EB
$262M
| $166K | ﹤0.01% |
49,323
-38,705
| -44% | -$130K |
|
2966
NovaGold Resources
NG
$2.82B
| $165K | ﹤0.01% |
49,681
-19,586
| -28% | -$65.2K |
|
2967
Marcus & Millichap
MMI
$1.26B
| $165K | ﹤0.01% |
4,324
-841
| -16% | -$32.2K |
|
2968
First Hawaiian
FHB
$3.19B
| $165K | ﹤0.01% |
6,373
-19,979
| -76% | -$518K |
|
2969
Praxis Precision Medicines
PRAX
$794M
| $165K | ﹤0.01% |
2,142
-7,383
| -78% | -$568K |
|
2970
NextNav
NN
$2.3B
| $164K | ﹤0.01% |
+10,570
| New | +$164K |
|
2971
Nurix Therapeutics
NRIX
$691M
| $164K | ﹤0.01% |
+8,700
| New | +$164K |
|
2972
AudioEye
AEYE
$166M
| $164K | ﹤0.01% |
10,768
-434
| -4% | -$6.6K |
|
2973
VEON
VEON
$3.71B
| $163K | ﹤0.01% |
+4,065
| New | +$163K |
|
2974
Perspective Therapeutics
CATX
$258M
| $163K | ﹤0.01% |
51,094
+3,529
| +7% | +$11.3K |
|
2975
Phreesia
PHR
$1.45B
| $163K | ﹤0.01% |
+6,468
| New | +$163K |
|